Aytu Biopharma (AYTU) Profit After Tax (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Profit After Tax of -$5.6 million for Q1 2026, down 240.66% year-over-year from $4.0 million in Q1 2025, and up 46.92% quarter-over-quarter from -$10.6 million in Q4 2025.
Aytu Biopharma (AYTU) Profit After Tax (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Profit After Tax for 17 consecutive years, with -$5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 240.66% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at -$34.7 million (down 798.67% YoY), while the FY2025 annual figure was -$14.2 million, down 13.27% from the prior year.
- Profit After Tax climbed to -$5.6 million in Q1 2026 per AYTU's latest filing, from -$10.6 million in the prior quarter.
- Across five years, Profit After Tax topped out at $4.0 million in Q1 2025 and bottomed at -$53.3 million in Q1 2022.
- Historically, Profit After Tax has averaged -$7.5 million across 5 years, with a median of -$2.5 million in 2023.
- Annual changes were most pronounced in 2024 — Profit After Tax surged 458.18% — and 2025, when it slumped 1480.67%.
- Aytu Biopharma's Profit After Tax stood at -$6.7 million in 2022, then surged by 96.71% to -$220000.0 in 2023, then soared by 458.18% to $788000.0 in 2024, then plunged by 1443.15% to -$10.6 million in 2025, then jumped by 46.92% to -$5.6 million in 2026.
- Business Quant data shows AYTU's Profit After Tax at -$5.6 million in Q1 2026, -$10.6 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn | -5.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.62 Mn |
| Dec 31, 2025 | -10.58 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | -20.44 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | -2.29 Mn |
| Dec 31, 2023 | -220,000.00 |
| Sep 30, 2023 | -8.12 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -7.20 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | -16.09 Mn |
| Mar 31, 2022 | -53.29 Mn |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -27.85 Mn |
| Jun 30, 2021 | -19.00 Mn |